March 22, 2018 / 7:30 PM / a month ago

BRIEF-FDA Continues To Recommend Magellan Lead Tests Not Be Used With Samples Taken From Vein

March 22 (Reuters) - U.S. FDA :

* U.S FDA PROVIDES STATEMENT ON FINDINGS FROM ONGOING INVESTIGATION INTO LEAD TESTING ISSUES

* U.S. FDA-CONCLUDED THAT STUDIES PERFORMED BY BD WERE ROBUST & SHOWED THERE WAS SIGNIFICANT CHANCE OF FALSE RESULTS WITH MAGELLAN’S LEADCARE TESTS ‍​

* U.S FDA SAYS CONTINUES TO RECOMMEND THAT MAGELLAN LEAD TESTS NOT BE USED WITH BLOOD SAMPLES TAKEN FROM THE VEIN

* U.S FDA SAYS MAGELLAN’S LEAD TEST SYSTEMS CAN CONTINUE TO BE USED WITH BLOOD SAMPLES FROM A FINGER OR HEEL STICK

* AT FDA'S REQUEST, BD IS CONDUCTING TESTING TO DETERMINE IF LAB TESTS OTHER THAN MAGELLAN LEAD TESTS ARE AFFECTED BY THIURAM INTERFERENCE​‍​ Source text: (bit.ly/2G1K6io) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below